MTMT-ben szereplő publikációk tallózása szerző szerint "Schreiber, S"

1-3 / 3

Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation

Ben-Horin, S; Casteele, NV; Schreiber, S; Lakatos, Péter László (2016)
Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, Petra; Gulácsi, László; Brodszky, Valentin; Végh, Zsuzsanna; Danese, S; Irving, PM; Peyrin, Biroulet L; Schreiber, S; Rencz, Fanni; Lakatos, Péter László; Péntek, Márta (2018)

Background: In clinical practice, treatment sequences of biologicals are applied for active fistulising Crohn's disease, however underlying health economic analyses are lacking.
Development of an index to define overall disease severity in IBD

Siegel, CA; Whitman, CB; Spiegel, BM; Feagan, B; Sands, B; Loftus, EV Jr; Panaccione, R; D'Haens, G; Bernstein, CN; Gearry, R; Ng, SC; Mantzaris, GJ; Sartor, B; Silverberg, MS; Riddell, R; Koutroubakis, IE; O'Morain, C; Lakatos, Péter László; McGovern, DP; Halfvarson, J; Reinisch, W; Rogler, G; Kruis, W; Tysk, C; Schreiber, S; Danese, S; Sandborn, W; Griffiths, A; Moum, B; Gasche, C; Pallone, F; Travis, S; Panes, J; Colombel, JF; Hanauer, S; Peyrin-Biroulet, L (2018)

1-3 / 3

Keresés